 |
|
|
 = Add Release to Briefcase |
| All Releases |
|---|
 |
ZIOPHARM Oncology to Present at the 22nd Annual Roth OC Growth Stock Conference
Mar 8, 2010
|
11.5 KB
|
| |
NEW YORK, Mar 08, 2010 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, will present at the 22nd
Annual Roth OC Growth Stock Conference on Monday, March 15, 2010 at 4:00
pm PT at the Ritz Carlton / Laguna Niguel, CA. Dr. Lewis will provide an
...
|
|
|
ZIOPHARM Oncology to Present at the Cowen and Company 30th Annual Health Care Conference
Mar 4, 2010
|
11.5 KB
|
| |
NEW YORK, Mar 04, 2010 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, will present at the Cowen and
Company 30th Annual Health Care Conference on Thursday, March
11, 2010 at 11:05 am at the Boston Marriott Copley Place in Boston, MA.
Dr...
|
|
|
Dr. Lewis to Participate in the Inaugural University College London UCL Finance Conference
Feb 8, 2010
|
12.8 KB
|
| |
NEW YORK, Feb 08, 2010 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, has been invited to present at
the Inaugural UCL One Day Finance Conference to be held on February 15th.
The event will take place in London, England at the BMA (British Medi...
|
|
|
Dr. Lewis to Serve on Sarcoma Panel
Feb 1, 2010
|
12.5 KB
|
| |
NEW YORK, Feb 01, 2010 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, has been invited to participate
as a panelist at the BIO CEO Therapeutic Workshop: Connecting the Dots
on Sarcoma Treatments on February 8th from 12:00pm - 1:00pm
at ...
|
|
|
Dr. Lewis to Participate as Chairman and Invited Lecturer at the 2nd Annual International Conference on Drug Discovery & Therapy, Dubai, UAE
Jan 27, 2010
|
12.6 KB
|
| |
NEW YORK, Jan 27, 2010 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, has been invited to participate
at the 2nd International Conference on Drug Discovery and
Therapy in Dubai, United Arab Emirates as:
Chairman of Translational Biom...
|
|
|
ZIOPHARM Receives Important Palifosfamide U.S. Patent Allowance
Jan 26, 2010
|
12.2 KB
|
| |
NEW YORK, Jan 26, 2010 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it has
received a Notice of Allowance from the U.S. Patent and Trademark Office
for Application Serial No. 11/257,766 entitled "Salts of
Isophosphoramide mustard and analogs thereof as anti-tumor agents" with
claims ...
|
|
|
ZIOPHARM Oncology to Present at the Biotech ShowcaseTM, San Francisco 2010
Jan 6, 2010
|
13.1 KB
|
| |
NEW YORK, Jan 06, 2010 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, will present at the Biotech
ShowcaseTM 2010 on Tuesday, January 12, 2010 at 2:40 pm PT at
the Marines' Memorial Club & Hotel in San Francisco, CA. Dr. Lewis will
prov...
|
|
|
ZIOPHARM Prices Public Offering
Dec 4, 2009
|
11.9 KB
|
| |
NEW YORK, Dec 04, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the pricing of its
previously announced underwritten public offering of 15,484,000 shares
of its common stock and warrants to purchase 7,742,000 shares of its
common stock at a public offering price of $3.10 per unit. The warrants,
...
|
|
|
ZIOPHARM Announces Commencement of Public Offering
Dec 3, 2009
|
11.4 KB
|
| |
NEW YORK, Dec 03, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that it intends
to offer shares of its common stock and warrants to purchase shares of
its common stock in a public offering. JMP Securities LLC and Rodman &
Renshaw, LLC are acting as co-lead managers for the offering.
The Comp...
|
|
|
ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress
Nov 11, 2009
|
12.9 KB
|
| |
NEW YORK, Nov 11, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a biopharmaceutical company that
is seeking to develop and commercialize a diverse, risk sensitive
portfolio of in-licensed cancer drugs addressing unmet medical needs,
today reported its financial results for the quarter ended September 30,
...
|
|
|
ZIOPHARM to Host Analyst & Institutional Investor Meeting on November 19, 2009
Nov 9, 2009
|
12.0 KB
|
| |
NEW YORK, Nov 09, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Company
will host an analyst and institutional investor meeting on Thursday,
November 19, 2009 from 7:30 A.M. to 9:30 A.M. Eastern Time in New York
City.
The event will be moderated by Jonathan Lewis, MD, PhD, Chief Exe...
|
|
|
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
Nov 6, 2009
|
15.5 KB
|
| |
NEW YORK, Nov 06, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) presented today at the 15th
Annual Connective Tissue Oncology Society (CTOS) Meeting, positive
interim data from the multicenter randomized Phase II trial of
palifosfamide (ZymafosTM, ZIO-201) treating patients with
unresectable or metas...
|
|
|
ZIOPHARM Oncology to Present at the Merriman, Curhan, Ford Investor Summit 2009
Nov 3, 2009
|
11.9 KB
|
| |
NEW YORK, Nov 03, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, will present at the 6th
Annual Merriman, Curhan, Ford Investor Summit on Tuesday, November 10,
2009 at 12:20 pm ET at the Soffitel Hotel in New York, NY. Dr. Lewis
wi...
|
|
|
-- ZIOPHARM Oncology to Present at the 8th Annual BIO Investor Forum --
Oct 22, 2009
|
11.9 KB
|
| |
NEW YORK, Oct 22, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, will present at the 8th
Annual BIO Investor Forum on Thursday, October 29, 2009 at 10:00 am PT
at the Palace Hotel in San Francisco, CA. Dr. Lewis will provide an
ove...
|
|
|
ZIOPHARM Announces Positive Palifosfamide Sarcoma Randomized Phase II Interim Data: Trial Enrollment Stopped Early
Oct 14, 2009
|
13.0 KB
|
| |
NEW YORK, Oct 14, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today positive top line
interim data from the multicenter randomized Phase II trial of
palifosfamide (ZymafosTM, ZIO-201) treating patients with
unresectable or metastatic soft tissue sarcoma. The analysis evaluated
62 patients...
|
|
|
ZIOPHARM Oncology to Present at the 4th Annual JMP Healthcare Focus Conference
Sep 30, 2009
|
11.8 KB
|
| |
NEW YORK, Sep 30, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, will present at the 4th
Annual JMP Securities Healthcare Focus Conference on Monday, October 5,
2009 at 3:00 pm ET at the New York Palace Hotel in New York City. Dr.
...
|
|
|
ZIOPHARM Oncology to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
Sep 9, 2009
|
11.8 KB
|
| |
NEW YORK, Sep 09, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, will present at the Rodman &
Renshaw 11th Annual Healthcare Conference on Thursday,
September 10, 2009 at 10:00 am ET at the New York Palace Hotel in New
York City. D...
|
|
|
ZIOPHARM Announces At Market Private Placement of $5.05 Million
Sep 9, 2009
|
12.2 KB
|
| |
NEW YORK, Sep 09, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that it has
entered into definitive agreements with both existing and new investors
to raise approximately $5.05 million in gross proceeds, before deducting
placement agent fees and estimated offering expenses, in a private
...
|
|
|
ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs
Aug 14, 2009
|
12.5 KB
|
| |
NEW YORK, Aug 14, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a biopharmaceutical company that
is seeking to develop and commercialize a diverse, risk sensitive
portfolio of in-licensed cancer drugs addressing unmet medical needs,
today reported its financial results for the quarter ended June 30, 2009
...
|
|
|
ZIOPHARM Oncology to Present at the 8th Annual Needham Life Sciences Conference
Jun 3, 2009
|
11.4 KB
|
| |
NEW YORK, Jun 03, 2009 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, will present at the 8th
Annual Needham Life Sciences Conference on Thursday, June 11, 2009 at
11:00 am ET at the New York Palace Hotel in New York City. Dr. Lewis
wil...
|
|
|
| |
Recent Releases
Mar 8, 2010
ZIOPHARM Oncology to Present at the 22nd Annual Roth OC Growth Stock Conference
Mar 4, 2010
ZIOPHARM Oncology to Present at the Cowen and Company 30th Annual Health Care Conference
Feb 8, 2010
Dr. Lewis to Participate in the Inaugural University College London UCL Finance Conference
more »
|
